MedTech Strategist, the global medical device industry's most trusted resource, will help you stay ahead of the opportunities and obstacles that are impacting your corporate strategy. We invite you to explore our coverage. Think Strategically. Subscribe Today
Browse Latest Issue
The Women’s Brain Foundation is out to demonstrate that sex- and gender-specific precision medicine is not only cost-effective healthcare, it’s also a way to derisk both pharma and device therapy development, and not just for diseases that only affect women.
On the heels of Fasikl’s successful TRANQUIL study, FDA approves its combination of sophisticated AI and non- to minimally invasive stimulation.
In this month's news, 510(k)s for ENT devices, Zimmer Biomet buys Monogram, clearances for Tissium and Anaconda Biomed, and more.